S137: IMPACT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN FIRST COMPLETE REMISSION PLUS FLT3 INHIBITION WITH QUIZARTINIB IN ACUTE MYELOID LEUKEMIA WITH FLT3-ITD: RESULTS FROM QUANTUM-FIRST

• Richard Schlenk,
• Pau Montesinos,
• Antonio Romero-Aguilar,
• Radovan Vrhovac,
• Elżbieta Patkowska,
• Hee-Je Kim,
• Pavel Zak,
• Po-Nan Wang,
• James Hanyok,
• LI Liu,
• Yasser Mostafa Kamel,
• Aziz Benzohra,
• Arnaud Lesegretain,
• Jorge Cortes,
• Mikkael A. Sekeres,
• Hervé Dombret,
• Sergio Amadori,
• Jianxiang Wang,
• Alexander E. Perl,
• Mark J. Levis,
• Harry P. Erba

Affiliations

Richard Schlenk

1 Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany

Pau Montesinos

2 La Fe University and Polytechnic Hospital, Valencia, Spain

Antonio Romero-Aguilar

3 University Hospital Virgen de las Nieves, Granada, Spain

Radovan Vrhovac

4 University Hospital Centre Zagreb, Zagreb, Croatia

Elżbieta Patkowska

5 Institute of Hematology and Blood Transfusion, Warsaw, Poland

Hee-Je Kim

6 Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Rep. of South

Pavel Zak

7 University Hospital Hradec Kralove, Hradec Kralove, Czech Republic

Po-Nan Wang

8 Chang Gung Medical Foundation, Linkou, Taiwan

James Hanyok

9 Daiichi Sankyo, Inc., Basking Ridge, United States

LI Liu

9 Daiichi Sankyo, Inc., Basking Ridge, United States

Yasser Mostafa Kamel

9 Daiichi Sankyo, Inc., Basking Ridge, United States

Aziz Benzohra

9 Daiichi Sankyo, Inc., Basking Ridge, United States

Arnaud Lesegretain

9 Daiichi Sankyo, Inc., Basking Ridge, United States

Jorge Cortes

10 Augusta University Medical Center, Augusta, United States

Mikkael A. Sekeres

11 Sylvester Cancer Center, University of Miami Health System, Miami, United States

Hervé Dombret

12 Saint Louis Hospital, University of Paris, Paris, France

Sergio Amadori

13 Tor Vergata Polyclinic Hospital Rome, Rome, Italy

Jianxiang Wang

14 Institute of Hematology and Blood Diseases Hospital, Tianjin, China

Alexander E. Perl

15 University of Pennsylvania, Philadelphia, United States

Mark J. Levis

16 Johns Hopkins University, Baltimore, United States

Harry P. Erba

17 Duke Cancer Institute, Durham, United States